CMS certification 310108
Jfk University Medical Center
65 James Street, Edison, NJ 08818
Jfk University Medical Center has a CMS overall rating of 3 out of 5 stars. 56% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. Emergency patients spend a median of 3 h 17 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 2,038 completed surveys, 15% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NJ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 380 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 17 min | 3 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 14 visits sampled | 7 h 32 min | 4 h 52 min | 4 h 17 min |
| Left before being seen Lower is better · 93,785 patients | 2% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 153 patients | 62% | 73% | 65% |
How Jfk University Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Jfk University Medical CenterThis hospital | 3/5 | 56% | 3 h 17 min | 4 better 2 worse |
| Raritan Bay Medical CenterSame county · Perth Amboy | 4/5 | 61% | 2 h 58 min | 2 better 2 worse |
| Robert Wood Johnson University HospitalSame county · New Brunswick | 2/5 | 70% | 3 h 26 min | 4 better 6 worse |
| Saint Peter's University HospitalSame county · New Brunswick | 3/5 | 76% | 3 h 28 min | 3 better 3 worse |
| University Medical Center of Princeton at PlainsboroSame county · Plainsboro | 4/5 | 75% | 3 h 41 min | 4 better 2 worse |
| Hunterdon Medical CenterSame ZIP area · Flemington | 4/5 | 62% | 3 h 50 min | 2 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,256 cases | Too few cases | 3.6% | 3.9% |
| Heart attack 143 cases | Too few cases | 12.7% | 11.9% |
| Heart failure 657 cases | Too few cases | 10.9% | 11.1% |
| Pneumonia 1,095 cases | Too few cases | 15.9% | 15.2% |
| Stroke 565 cases | Too few cases | 9.7% | 11.9% |
| COPD 179 cases | Too few cases | 6.7% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.15 likely 0.86 – 1.44 | 1 |
| Deaths after a serious but treatable surgical complication 134 cases | No different | 128.52 per 1,000 likely 82.09 per 1,000 – 174.95 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 8,469 cases | No different | 0.41 per 1,000 likely 0 per 1,000 – 0.92 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 9,418 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.41 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,763 cases | No different | 0.22 per 1,000 likely 0.04 per 1,000 – 0.4 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,494 cases | No different | 2.01 per 1,000 likely 0.59 per 1,000 – 3.43 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 476 cases | No different | 1.89 per 1,000 likely 0.26 per 1,000 – 3.51 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 381 cases | Worse | 17.74 per 1,000 likely 10.71 per 1,000 – 24.77 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,533 cases | No different | 2.49 per 1,000 likely 0.53 per 1,000 – 4.44 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 454 cases | No different | 6.69 per 1,000 likely 3.17 per 1,000 – 10.22 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 336 cases | No different | 1.58 per 1,000 likely 0.13 per 1,000 – 3.02 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,675 cases | No different | 0.94 per 1,000 likely 0.03 per 1,000 – 1.85 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.46 likely 0.17 – 1.03 | 1 |
| Surgical site infections after colon surgery | No different | 0.22 likely 0.01 – 1.11 | 1 |
| MRSA bloodstream infections | No different | 1.02 likely 0.45 – 2.01 | 1 |
| C. diff intestinal infections | Better | 0.11 likely 0.05 – 0.22 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 134 cases | Too few cases | 13.4% | 14.4% |
| Readmitted after heart failure 913 cases | Too few cases | 22.1% | 21.3% |
| Readmitted after pneumonia 1,375 cases | Too few cases | 17% | 17.3% |
| Readmitted after COPD 290 cases | Too few cases | 19.1% | 20% |
| Days back in hospital after a heart attack 107 cases | Too few cases | 15.6 days per 100 | — |
| Days back in hospital after heart failure 680 cases | Too few cases | 16.8 days per 100 | — |
| Days back in hospital after pneumonia 1,124 cases | Too few cases | 29.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 519 cases | No different | 11.9 per 1,000 likely 9 per 1,000 – 15.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 82 cases | No different | 13.3 per 100 likely 9.6 per 100 – 18 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 82 cases | No different | 4.7 per 100 likely 3.1 per 100 – 7.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 538 cases | No different | 1.1 likely 0.8 – 1.4 | — |
3 more measures had too few cases here to report.
Clinicians registered at this address
11 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 2 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Clinical | 3 |
| Neurology | 2 |
| Acute Care | 1 |
| Addiction (Substance Use Disorder) | 1 |
| Internal Medicine | 1 |
| Neurology with Special Qualifications in Child Neurology | 1 |
| Physician Assistant | 1 |
| Surgical | 1 |
First 11 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $178,305
- 2020 $73,543
- 2021 $24,552
- 2022 $76,509
- 2023 $1M
- 2024 $968,509
- 2025 $1.2M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Education | $17,500 | 1 |
| Space rental and facility fees | $10,000 | 2 |
| Debt forgiveness | $948 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Celgene Corporation | $608,237 | 10 |
| E.R. Squibb & Sons, L.L.C. | $285,628 | 4 |
| Abbvie INC. | $144,271 | 39 |
| Genmab U.S., Inc. | $139,111 | 11 |
| Medtronic, Inc. | $17,060 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $5,900 | 1 |
| Genentech, Inc. | $5,463 | 3 |
| Genentech USA, Inc. | $5,000 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 1, Multicenter, Single-arm, Dose-escalation Study Of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Eval… E.R. Squibb & Sons, L.L.C. | $309,439 |
| A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination with Rituximab in Patients with Newly Diagno… Celgene Corporation | $221,244 |
| A Phase 1, Multi-center, Open-label, Dose Finding Study of CC-96191 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia Celgene Corporation | $166,203 |
| A Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma. Genmab U.S., Inc. | $136,361 |
| Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Vol… ABBVIE INC. · NCT04472598 | $75,394 |
| A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinatio… Celgene Corporation | $47,032 |
| An Exploratory Phase 1b Open-Label Multi-Arm Trial to Evaluate the Safety and Efficacy of CC-90009 in Combination with Anti-Leukemia Agents in Subjec… Celgene Corporation | $41,080 |
| A Phase 1/2, Multi-center, Open-label Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of an Orally Available Small Molecule, C… Celgene Corporation | $32,672 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Jfk University Medical Center
Is Jfk University Medical Center a good hospital?
Jfk University Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Jfk University Medical Center?
56% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 2,038 completed HCAHPS surveys.
How long is the wait in the Jfk University Medical Center emergency room?
Emergency patients spend a median of 3 h 17 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Jfk University Medical Center receive money from drug and device companies?
Drug and device makers reported $1.2M in payments to Jfk University Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.